GAITHERSBURG, Md., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 23, 2017 at 5:00 pm (Eastern Time) to discuss the financial results for the fourth quarter and full twelve months of 2016, recent business developments, financial outlook for full year 2017, and revenue guidance for the first quarter of 2017.
This conference call can be accessed live by telephone or via webcast:
|Live Teleconference Information:|
|Dial in number: (855) 766-6521|
|International dial in: (262) 912-6157|
|Conference ID: 29688886|
|Live Webcast Information:|
|Visit edge.media-server.com/m/p/qbs3g23i for the live webcast feed.|
About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at emergentbiosolutions.com. Follow us @emergentbiosolu.
Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280 BurrowsR@ebsi.com Media Contact: Tracey Schmitt Lintott Senior Vice President, Global Public Affairs 240-631-3281 SchmittT@ebsi.com
Source:Emergent BioSolutions Inc.